Robert A Copeland Insider Trading $EPZM Epizyme, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert A Copeland.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert A Copeland. Robert A Copeland is EVP and CSO in Epizyme, Inc. ($EPZM) and President of Research and CSO in Epizyme, Inc. ($EPZM).
Robert A Copeland in Epizyme, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert A Copeland: President of Research and CSO, EVP and CSO
Holdings: 34,038 shares
Current Value: $410,158
Latest Transaction: Jun 07 2017
$EPZM Market Capitalization: $707.73M
$EPZM Previous Close: $12.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Robert A Copeland in Epizyme, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 07 2017 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 3.54 | 2,500 | 8,850 | 36,050 | |
| Jun 07 2017 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 13.45 | 2,500 | 33,625 | 31,538 | 34 K to 31.5 K (-7.34 %) |
| Jun 07 2017 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 3.54 | 2,500 | 8,850 | 34,038 | 31.5 K to 34 K (+7.93 %) |
| May 03 2017 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 3.54 | 5,000 | 17,700 | 38,550 | |
| May 03 2017 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 17.44 | 5,000 | 87,213 | 31,538 | 36.5 K to 31.5 K (-13.68 %) |
| May 03 2017 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 3.54 | 5,000 | 17,700 | 36,538 | 31.5 K to 36.5 K (+15.85 %) |
| Apr 05 2017 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 3.54 | 3,000 | 10,620 | 43,550 | |
| Apr 05 2017 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 2.19 | 2,000 | 4,380 | 0 | |
| Apr 05 2017 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 16.36 | 2,500 | 40,896 | 31,538 | 34 K to 31.5 K (-7.34 %) |
| Apr 05 2017 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 16.36 | 2,500 | 40,909 | 34,038 | 36.5 K to 34 K (-6.84 %) |
| Apr 05 2017 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 3.54 | 3,000 | 10,620 | 36,538 | 33.5 K to 36.5 K (+8.95 %) |
| Apr 05 2017 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 2.19 | 2,000 | 4,380 | 33,538 | 31.5 K to 33.5 K (+6.34 %) |
| Feb 09 2017 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | A | 12.45 | 97,659 | 1,215,855 | 97,659 | |
| Aug 03 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 2.19 | 4,000 | 8,760 | 2,000 | |
| Aug 03 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 10.37 | 4,000 | 41,492 | 31,538 | 35.5 K to 31.5 K (-11.26 %) |
| Aug 03 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 2.19 | 4,000 | 8,760 | 35,538 | 31.5 K to 35.5 K (+12.68 %) |
| Jul 07 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 2.19 | 4,000 | 8,760 | 6,000 | |
| Jul 07 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 10.03 | 4,000 | 40,128 | 0 | 4 K to 0 (-100.00 %) |
| Jul 07 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 2.19 | 4,000 | 8,760 | 4,000 | 0 to 4 K |
| Jun 02 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 3.54 | 31,538 | 111,645 | 4,098 | |
| Jun 02 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 3.54 | 31,538 | 111,645 | 31,538 | 0 to 31.5 K |
| Feb 10 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | A | 8.98 | 122,200 | 1,097,356 | 122,200 | |
| Jan 04 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 2.19 | 3,893 | 8,526 | 10,000 | |
| Jan 04 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 3.54 | 292 | 1,034 | 28,806 | |
| Jan 04 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 15.58 | 3,893 | 60,635 | 0 | 3.9 K to 0 (-100.00 %) |
| Jan 04 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 2.19 | 3,893 | 8,526 | 3,893 | 0 to 3.9 K |
| Jan 04 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 15.58 | 292 | 4,548 | 0 | 292 to 0 (-100.00 %) |
| Jan 04 2016 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 3.54 | 292 | 1,034 | 292 | 0 to 292 |
| Dec 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 2.19 | 2,503 | 5,482 | 13,893 | |
| Dec 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 0.60 | 1,682 | 1,009 | 0 | |
| Dec 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 13.82 | 2,503 | 34,595 | 0 | 2.5 K to 0 (-100.00 %) |
| Dec 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 2.19 | 2,503 | 5,482 | 2,503 | 0 to 2.5 K |
| Dec 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 13.82 | 1,682 | 23,248 | 0 | 1.7 K to 0 (-100.00 %) |
| Dec 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 0.60 | 1,682 | 1,009 | 1,682 | 0 to 1.7 K |
| Nov 10 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 0.60 | 4,185 | 2,511 | 1,682 | |
| Nov 10 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 16.26 | 4,185 | 68,059 | 0 | 4.2 K to 0 (-100.00 %) |
| Nov 10 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 0.60 | 4,185 | 2,511 | 4,185 | 0 to 4.2 K |
| Oct 05 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 0.60 | 4,185 | 2,511 | 5,867 | |
| Oct 05 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 14.43 | 4,185 | 60,380 | 0 | 4.2 K to 0 (-100.00 %) |
| Oct 05 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 0.60 | 4,185 | 2,511 | 4,185 | 0 to 4.2 K |
| Sep 10 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 0.60 | 4,185 | 2,511 | 10,052 | |
| Sep 10 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 19.58 | 4,185 | 81,921 | 0 | 4.2 K to 0 (-100.00 %) |
| Sep 10 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 0.60 | 4,185 | 2,511 | 4,185 | 0 to 4.2 K |
| Aug 05 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 0.60 | 8,370 | 5,022 | 14,237 | |
| Aug 05 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 22.19 | 8,370 | 185,727 | 0 | 8.4 K to 0 (-100.00 %) |
| Aug 05 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 0.60 | 8,370 | 5,022 | 8,370 | 0 to 8.4 K |
| Jul 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 0.60 | 7,121 | 4,273 | 22,607 | |
| Jul 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | M | 0.51 | 1,250 | 638 | 0 | |
| Jul 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 22.82 | 4,185 | 95,520 | 0 | 4.2 K to 0 (-100.00 %) |
| Jul 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Sell | S | 22.90 | 4,186 | 95,879 | 4,185 | 8.4 K to 4.2 K (-50.01 %) |
| Jul 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 0.60 | 7,121 | 4,273 | 8,371 | 1.3 K to 8.4 K (+569.68 %) |
| Jul 08 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Buy | M | 0.51 | 1,250 | 638 | 1,250 | 0 to 1.3 K |
| Feb 17 2015 | EPZM | Epizyme, Inc. | Copeland Robert A | President of Resear ... | Option Exercise | A | 21.58 | 65,052 | 1,403,822 | 65,052 | |
| Nov 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 2.19 | 20,000 | 43,800 | 16,396 | |
| Nov 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 22.68 | 20,000 | 453,636 | 0 | 20 K to 0 (-100.00 %) |
| Nov 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 2.19 | 20,000 | 43,800 | 20,000 | 0 to 20 K |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 2.19 | 13,414 | 29,377 | 36,396 | |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.60 | 6,586 | 3,952 | 29,728 | |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 26.10 | 3,700 | 96,566 | 0 | 3.7 K to 0 (-100.00 %) |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 25.33 | 16,300 | 412,934 | 3,700 | 20 K to 3.7 K (-81.50 %) |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 2.19 | 13,414 | 29,377 | 20,000 | 6.6 K to 20 K (+203.67 %) |
| Nov 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.60 | 6,586 | 3,952 | 6,586 | 0 to 6.6 K |
| Oct 09 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.60 | 20,000 | 12,000 | 36,314 | |
| Oct 09 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 27.74 | 1,000 | 27,740 | 0 | 1,000 to 0 (-100.00 %) |
| Oct 09 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 26.86 | 19,000 | 510,291 | 1,000 | 20 K to 1,000 (-95.00 %) |
| Oct 09 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.60 | 20,000 | 12,000 | 20,000 | 0 to 20 K |
| Sep 24 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.60 | 20,000 | 12,000 | 56,314 | |
| Sep 24 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 25.55 | 20,000 | 510,990 | 0 | 20 K to 0 (-100.00 %) |
| Sep 24 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.60 | 20,000 | 12,000 | 20,000 | 0 to 20 K |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 36.52 | 1,326 | 48,422 | 0 | 1.3 K to 0 (-100.00 %) |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 35.93 | 4,199 | 150,852 | 1,326 | 5.5 K to 1.3 K (-76.00 %) |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 36.52 | 1,274 | 46,523 | 0 | 1.3 K to 0 (-100.00 %) |
| Aug 19 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 35.93 | 4,031 | 144,816 | 1,274 | 5.3 K to 1.3 K (-75.98 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.60 | 20,000 | 12,000 | 76,314 | |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 29.88 | 8,427 | 251,784 | 5,305 | 13.7 K to 5.3 K (-61.37 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 29.08 | 11,573 | 336,563 | 13,732 | 25.3 K to 13.7 K (-45.73 %) |
| Aug 05 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.60 | 20,000 | 12,000 | 25,305 | 5.3 K to 25.3 K (+377.00 %) |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.60 | 13,450 | 8,070 | 96,314 | |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.51 | 6,550 | 3,341 | 1,250 | |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 28.88 | 5,184 | 149,715 | 5,305 | 10.5 K to 5.3 K (-49.42 %) |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 28.26 | 14,816 | 418,697 | 10,489 | 25.3 K to 10.5 K (-58.55 %) |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.60 | 13,450 | 8,070 | 25,305 | 11.9 K to 25.3 K (+113.45 %) |
| Jun 25 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.51 | 6,550 | 3,341 | 11,855 | 5.3 K to 11.9 K (+123.47 %) |
| Jun 18 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 26.38 | 12,756 | 336,540 | 5,525 | 18.3 K to 5.5 K (-69.78 %) |
| Jun 18 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 26.38 | 12,256 | 323,349 | 5,305 | 17.6 K to 5.3 K (-69.79 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.51 | 38,400 | 19,584 | 7,800 | |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 23.21 | 3,100 | 71,950 | 17,561 | 20.7 K to 17.6 K (-15.00 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 22.21 | 35,300 | 784,115 | 20,661 | 56 K to 20.7 K (-63.08 %) |
| Jun 04 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.51 | 38,400 | 19,584 | 55,961 | 17.6 K to 56 K (+218.67 %) |
| May 21 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 22.28 | 2,550 | 56,804 | 18,281 | 20.8 K to 18.3 K (-12.24 %) |
| May 21 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 22.28 | 2,450 | 54,576 | 17,561 | 20 K to 17.6 K (-12.24 %) |
| May 05 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 21.29 | 5,100 | 108,571 | 20,831 | 25.9 K to 20.8 K (-19.67 %) |
| May 05 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 21.29 | 4,900 | 104,313 | 20,011 | 24.9 K to 20 K (-19.67 %) |
| Apr 30 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 0.51 | 13,800 | 7,038 | 46,200 | |
| Apr 30 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 20.73 | 13,800 | 286,085 | 24,911 | 38.7 K to 24.9 K (-35.65 %) |
| Apr 30 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 0.51 | 13,800 | 7,038 | 38,711 | 24.9 K to 38.7 K (+55.40 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 29.25 | 19,179 | 560,986 | 24,911 | 44.1 K to 24.9 K (-43.50 %) |
| Jan 30 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | A | 31.20 | 27,406 | 855,067 | 27,406 | |
| Jan 15 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 39.86 | 2,266 | 90,319 | 25,931 | 28.2 K to 25.9 K (-8.04 %) |
| Jan 15 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 38.86 | 3,286 | 127,697 | 28,197 | 31.5 K to 28.2 K (-10.44 %) |
| Jan 15 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 39.86 | 3,858 | 153,773 | 44,090 | 47.9 K to 44.1 K (-8.05 %) |
| Jan 15 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 38.86 | 5,596 | 217,465 | 47,948 | 53.5 K to 47.9 K (-10.45 %) |
| Dec 17 2013 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Option Exercise | M | 2.19 | 4,600 | 10,074 | 49,810 | |
| Dec 17 2013 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 21.21 | 4,600 | 97,545 | 53,544 | 58.1 K to 53.5 K (-7.91 %) |
| Dec 17 2013 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Buy | M | 2.19 | 4,600 | 10,074 | 58,144 | 53.5 K to 58.1 K (+8.59 %) |
| Dec 03 2013 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 20.70 | 1,850 | 38,288 | 31,483 | 33.3 K to 31.5 K (-5.55 %) |
| Dec 03 2013 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 20.70 | 3,150 | 65,194 | 53,544 | 56.7 K to 53.5 K (-5.56 %) |
Page: 1